Claire Fraser

Insider Reports History

Location
C/O Becton, Dickinson And Company, Franklin Lakes, NJ
Signature
Donna Kalazdy, by power of attorney for Claire Fraser
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Claire Fraser:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BECTON DICKINSON & CO Director Common Stock 23.1K $4.45M $192.30 Aug 8, 2025 Direct
Seres Therapeutics, Inc. Director Stock Option (right to buy) 6.45K Jul 1, 2025 Direct

Insider Reports Filed by Claire Fraser

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDX BECTON DICKINSON & CO Sep 10, 2025 1 -$172K 4 Sep 11, 2025 Director
BDX BECTON DICKINSON & CO Aug 8, 2025 1 -$166K 4 Aug 8, 2025 Director
MCRB Seres Therapeutics, Inc. Jul 1, 2025 1 $0 4 Jul 2, 2025 Director
MCRB Seres Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 Director
BDX BECTON DICKINSON & CO Jan 28, 2025 1 $0 4 Jan 30, 2025 Director
MCRB Seres Therapeutics, Inc. Apr 4, 2024 1 $0 4 Apr 8, 2024 Director
BDX BECTON DICKINSON & CO Jan 23, 2024 1 $0 4 Jan 25, 2024 Director
BDX BECTON DICKINSON & CO Aug 28, 2023 1 -$239K 4 Aug 30, 2023 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
BDX BECTON DICKINSON & CO Jan 24, 2023 1 $0 4 Jan 26, 2023 Director
MCRB Seres Therapeutics, Inc. Jan 4, 2023 1 $0 4 Jan 5, 2023 Director
MCRB Seres Therapeutics, Inc. Jan 4, 2023 0 $0 3 Jan 5, 2023 Director
BDX BECTON DICKINSON & CO Feb 8, 2022 1 -$228K 4 Feb 10, 2022 Director
BDX BECTON DICKINSON & CO Jan 25, 2022 1 $0 4 Jan 27, 2022 Director
BDX BECTON DICKINSON & CO Aug 18, 2021 1 -$97.4K 4 Aug 18, 2021 Director
BDX BECTON DICKINSON & CO May 27, 2021 1 -$94.1K 4 May 28, 2021 Director